ConductScience.org, home

Paper3932205

Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.

Choromanski L and 1 other. Infect Immun, 1985. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease. Papers, record 3932205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3932205

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.
PubMed
Journal
Infect Immun
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.52
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Choromanski LL
2Kuhn RER E

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chagas DiseaseMajor topic
Interleukin-2Major topic
Animals
Humans
Immunosuppression Therapy
Lymphocytes
Mice
Mice, Inbred C57BL
Reference Values
Spleen

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-13128NIAID NIH HHSUnited StatesR01AI013128PubMed and NIHNIH RePORTER
R22AI013128NIHNIH RePORTER
R37AI013128NIHNIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16443342Interleukin 2.Annu Rev Immunol1984https://conductscience.org/library/papers/6443342PubMed
26334136Treatment of immunodeficiency with interleukin-2: initial exploration.J Biol Response Mod1984https://conductscience.org/library/papers/6334136PubMed
3808508The effect of BCG on the course of experimental Chagas' disease in mice.Int J Parasitol1975https://conductscience.org/library/papers/808508PubMed
4402286Trypanosoma cruzi: immune destruction of parasitized mouse fibroblasts in vitro.Exp Parasitol1977https://conductscience.org/library/papers/402286PubMed
5307029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
6109508Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice.J Immunol1979https://conductscience.org/library/papers/109508PubMed
76767829Trypanosoma cruzi-induced suppression of the primary immune response in murine cell cultures to T-cell-dependent and -independent antigens.J Parasitol1980https://conductscience.org/library/papers/6767829PubMed
86781919Trypanosoma cruzi: effect on B-cell-responsive and -responding clones.Exp Parasitol1981https://conductscience.org/library/papers/6781919PubMed
96811661Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells.J Immunol1982https://conductscience.org/library/papers/6811661PubMed
106600178In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.J Immunol1983https://conductscience.org/library/papers/6600178PubMed
116601147The fate of interleukin-2 after in vivo administration.J Immunol1983https://conductscience.org/library/papers/6601147PubMed
126407015Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6407015PubMed
136411359Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response.Cell Immunol1983https://conductscience.org/library/papers/6411359PubMed
146225801Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice.J Immunol1983https://conductscience.org/library/papers/6225801PubMed
156607956The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.J Immunol1984https://conductscience.org/library/papers/6607956PubMed
166235290Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2.J Immunol1984https://conductscience.org/library/papers/6235290PubMed
176431001Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2.J Immunol1984https://conductscience.org/library/papers/6431001PubMed
186436379Suppressed antibody responses to sheep erythrocytes in mice with chronic Trypanosoma cruzi infections are restored with interleukin 2.J Immunol1984https://conductscience.org/library/papers/6436379PubMed
194615402Plaque forming cells: methodology and theory.Transplant Rev1974https://conductscience.org/library/papers/4615402PubMed

Download CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
27001816Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27001816PubMed
8982829Influence of immunoglobulin and interleukin 2 on the translocation of microorganisms from gut into blood.J Anat1996https://conductscience.org/library/papers/8982829PubMed
8288318Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?Immunology1993https://conductscience.org/library/papers/8288318PubMed
7591102Trypanosoma cruzi immunosuppressive factor decreases the interleukin-2 mRNA level in cultured normal activated human lymphocytes.Infect Immun1995https://conductscience.org/library/papers/7591102PubMed
3546134Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.Infect Immun1987https://conductscience.org/library/papers/3546134PubMed
3487507Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2.Infect Immun1986https://conductscience.org/library/papers/3487507PubMed
3275585Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.Infect Immun1988https://conductscience.org/library/papers/3275585PubMed
2948917Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.Infect Immun1987https://conductscience.org/library/papers/2948917PubMed
2663720Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.Infect Immun1989https://conductscience.org/library/papers/2663720PubMed
2491831Elevated environmental temperature enhances immunity in experimental Chagas' disease.Infect Immun1989https://conductscience.org/library/papers/2491831PubMed
2429922Repeated antigenic stimulation overcomes immunosuppression in experimental Chagas' disease.Immunology1986https://conductscience.org/library/papers/2429922PubMed
2209625Immunological aspects of fungal pathogenesis.Eur J Clin Microbiol Infect Dis1990https://conductscience.org/library/papers/2209625PubMed
1937796Effect of elevated environmental temperature on the antibody response of mice to Trypanosoma cruzi during the acute phase of infection.Infect Immun1991https://conductscience.org/library/papers/1937796PubMed
1894358Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.Infect Immun1991https://conductscience.org/library/papers/1894358PubMed
1748480Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.Immunology1991https://conductscience.org/library/papers/1748480PubMed
1698177Antigen-specific T-helper cells abrogate suppression in Trypanosoma cruzi-infected mice.Infect Immun1990https://conductscience.org/library/papers/1698177PubMed
1590674Use of immune modulators in nonspecific therapy of bacterial infections.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1590674PubMed
1500197Interleukin-2 receptors in experimental Chagas' disease.Infect Immun1992https://conductscience.org/library/papers/1500197PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3932205

GET https://conductscience.org/api/papers/v1/3932205/authors